OMERS ADMINISTRATION Corp Takes $708,000 Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

OMERS ADMINISTRATION Corp bought a new position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 4,000 shares of the biopharmaceutical company’s stock, valued at approximately $708,000. Other hedge funds and other institutional investors also recently added […]

Related Keywords

Michaelw Bonney , ,News Ratings For Alnylam Pharmaceuticals Daily ,Ameriprise Financial Inc ,Alnylam Pharmaceuticals ,Morgan Stanley ,Goldman Sachs Group ,Alnylam Pharmaceuticals Inc ,Norges Bank ,Alnylam Pharmaceuticals Profile ,Capital International Investors ,Alnylam Pharmaceuticals Trading Down ,York Mellon Corp ,Nasdaq ,Quarter For Alnylam Pharmaceuticals ,Jpmorgan Chase Co ,Free Report ,International Investors ,Vance Management ,New York Mellon Corp ,Ameriprise Financial ,Director Michael ,Pharmaceuticals Trading Down ,Get Free Report ,Chardan Capital ,Visit Holdingschannel ,Alnylam Pharmaceuticals Daily ,Nasdaq Alny ,Dalny ,Medical ,02043q10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,